Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis
about
Recent advances in anti-neutrophil cytoplasmic antibody-associated vasculitisClinical Predictors of Outcome in Patients with Anti-neutrophil Cytoplasmic Autoantibody-related Renal Vasculitis: Experiences from a Single-center.Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study.ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.Outcome and treatment of elderly patients with ANCA-associated vasculitis.Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse.Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.Predictors of relapses in ANCA-associated small vessel vasculitis with kidney involvement.Key advances in the clinical approach to ANCA-associated vasculitis.Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis.Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis.The long-term outcomes of systemic vasculitis.Maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: who needs what and for how long?Twenty-five years of RENHIS: a history of histopathological studies within EUVAS.Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis - still of value for our patients?Outcome of kidney transplantation in pediatric patients with ANCA-associated glomerulonephritis: a single-center experience.Clinical presentation and outcome of pediatric ANCA-associated glomerulonephritis.Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remClinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.[Therapy of ANCA-associated vasculitis with severe renal manifestation under routine conditions].[Prognosis and therapy of inflammatory rheumatic diseases : Impact of renal manifestations].Pneumo-Renal Syndrome in Anti- Neutrophil Cytoplasm Antibody (ANCA)-Associated Small-Vessel VasculitisTreatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case-control study.Biomarkers in connective tissue diseases.Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal outcome.Clinical, serological and histological determinants of patient and renal outcome in ANCA-associated vasculitis with renal involvement: an analysis from a referral centre.Unmet Needs in the Pathogenesis and Treatment of Vasculitides.Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes.Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.Connective tissue growth factor and the cicatrization of cellular crescents in ANCA-associated glomerulonephritis.Antineutrophil cytoplasmic antibody associated vasculitides with renal involvement: Open challenges in the remission induction therapy.Impact of Proteinase 3 versus Myeloperoxidase Positivity on Risk of End-Stage Renal Disease in ANCA-Associated Glomerulonephritis Stratified by Histological Classification: A Population-Based Cohort Study.Prognosis and Histological Classification in Elderly Patients with ANCA-Glomerulonephritis: A Registry-Based Cohort Study.
P2860
Q26751357-20E4FC64-C610-437C-8D67-CC82460DD9C6Q33608983-B93409E8-84A8-42EA-B7BB-C86170A800ECQ35673484-3EBB4C46-CDC1-4EDD-BD08-EC89B50849F4Q35678050-C8D59A67-2CA4-4DCC-B9D1-4F53756D14B7Q35816989-45B01F74-49BB-4AFD-A535-916B8B671926Q36104863-B971AE3F-BD0A-49DA-B650-A96E826D869AQ36223713-2B8A89B0-17D5-4A60-BE96-F784A06A09EDQ36242872-0D1A4A3F-8C63-4620-B51C-111BF8F9E8E8Q36744892-D15F83FC-C206-4C2E-BE12-E1F930009C17Q38224803-758B3CFC-572F-4EE1-B277-0F513B6D886EQ38260987-FAEE6520-F287-4940-ACAD-7258BEFE187CQ38293706-ABC47B39-00B5-4CC6-9CCC-1F170967519CQ38324168-C2418B94-5CB1-4C4B-8DB4-0371EC83159EQ38327634-DE3BD809-4A6A-41E6-938B-C97F6CA63463Q38389846-304DADBF-7BAB-492A-9557-A98096A5BBDAQ38543360-4AFA785D-8906-44C4-9D87-EB1FB9BC41B0Q38647588-A24486AB-FB8B-4544-B201-C8BB3E1D682DQ38966285-BE23FB30-B3F3-43F1-9D07-9B5F0201C367Q40727667-F254680C-6813-40DA-9CE8-EBE8A13BC79BQ40801867-40E24828-4A61-4FC2-87BB-78F881C845D8Q40867645-74D1624B-C32D-481D-A3EA-C4A4C326FBF1Q41746643-2B428E0E-06F6-46C9-9FCF-E7D1D4B98F4FQ42319739-138F7CF0-EE2C-4013-914D-33DC15BAD87DQ42697904-502EF5C4-ED02-474E-914B-11612CFA84F3Q47314399-4D646FC4-404E-4827-863A-92269FAEB195Q48192294-6F75820B-D5B2-416E-BE06-C12E1A77D92EQ48227464-A3EFD8FE-68C0-41AE-ACFD-E01A5B279364Q48592090-336508DF-50EC-433C-8990-209961DDC66FQ49691317-461DE401-43E6-462F-91C3-9B3C4A9587FFQ52901866-0EDF99B6-9DBD-40CB-A163-825E7C218261Q53527831-D53C614D-7951-42C1-AE81-D79DBEC73F18Q55340553-DEA6095D-DE2A-41AC-93E3-E4BB30CA8635Q55395279-598F654A-5F60-4DC6-ABED-4337F76AAB65Q55405504-F0EDF3DE-4CE0-41C7-91E9-3CA6FB1D5866
P2860
Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis
@en
Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis.
@nl
type
label
Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis
@en
Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis.
@nl
prefLabel
Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis
@en
Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis.
@nl
P2093
P2860
P356
P1476
Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis
@en
P2093
Anoek A E de Joode
Coen A Stegeman
Jan Stephan F Sanders
P2860
P304
P356
10.2215/CJN.01020113
P577
2013-07-11T00:00:00Z